“Low-Dose” Aprotinin Modifies Hemostasis but Not Proinflammatory Cytokine Release
- 31 January 1997
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 63 (1) , 68-73
- https://doi.org/10.1016/s0003-4975(96)00812-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in childrenThe Annals of Thoracic Surgery, 1996
- Influence of steroids on complement and cytokine generation after cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United KingdomThe Annals of Thoracic Surgery, 1993
- Aprotinin in perspectiveThe Annals of Thoracic Surgery, 1993
- Regulation of acute phase response after cardiopulmonary bypass by immunomodulationThe Annals of Thoracic Surgery, 1993
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Platelet protection by low-dose aprotinin in cardiopulmonary bypass: Electron microscopic studyThe Annals of Thoracic Surgery, 1993
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987